{{Rsnum
|rsid=2745761
|Gene=PLCB1
|Chromosome=20
|position=8297296
|Orientation=plus
|GMAF=0.0753
|Gene_s=PLCB1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 0.0 | 1.8 | 98.2
| HCB | 0.7 | 21.9 | 77.4
| JPT | 1.8 | 24.8 | 73.5
| YRI | 2.0 | 24.5 | 73.5
| ASW | 0.0 | 29.8 | 70.2
| CHB | 0.7 | 21.9 | 77.4
| CHD | 0.0 | 21.1 | 78.9
| GIH | 0.0 | 9.9 | 90.1
| LWK | 1.9 | 25.9 | 72.2
| MEX | 1.7 | 19.0 | 79.3
| MKK | 2.6 | 18.6 | 78.8
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22664479
|Trait=None
|Title=A genome-wide association study for irinotecan-related severe toxicities in patients with advanced non-small-cell lung cancer.
|RiskAllele=C
|Pval=0.000006
|OR=4.8000
|ORtxt=None
}}

{{on chip | Affy GenomeWide 6}}